Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Tests developed to make stage I trials safer

Scientists have developed new preclinical tests that show how the clinical trial disaster at Northwick Park hospital (PJ, 25 March 2006, p342) could have been prevented.

Standard preclinical tests did not predict the catastrophic reaction that ensued when the immunotherapy drug TGN1412 was administered to healthy volunteers.

“With hindsight testing this drug in man was a mistake, but at the time the standard required pre-clinical tests failed to predict the effects it would have on the six volunteers,” said Stephen Poole at the British Pharmacological Society’s meeting in Brighton on 15 December 2008.

Dr Poole and his colleagues from the National Institute for Biological Standards and Control reproduced in vitro the reaction suffered by the volunteers.

The preclinical work highlighted that it is important to ensure such drugs are not tested solely on immune cells in isolation and that having a mixed human cell culture of white blood cells and endothelial cells is a much better indicator of how this type of drug will react in vivo.

The scientists have also developed a technique that dries the drug onto a plastic surface, rather than testing it on cells as a solution in water, which they say has proven to be a more reliable indicator of how the drug will react in the human body.

However the research is still early, Dr Poole pointed out, and the reasons why the drug had such an adverse event in the clinic but not in preclinical studies are yet to be fully determined.

Citation: The Pharmaceutical Journal URI: 10043679

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.